GL1X · GenesisL1 explorer

MolNFT v1 · #117466 · protein

TGF-beta receptor type 2 kinase domain (E431A,R433A,E485A,K488A,R493A, R495A) in complex with 3-amino-6-[4-(2- HYDROXYETHYL)PHENYL]-N-[4- (morpholin-4-YL)PYRIDIN-3-yl] pyrazine-2-carboxamide

5E91 · TGF-beta receptor type-2: “TGF-beta receptor type 2 kinase domain (E431A,R433A,E485A,K488A,R493A, R495A) in complex with…”. X-ray diffraction, 1 ligand (5L4), 4 pockets (best druggability 0.67). MolNFT v1 #117466 on GenesisL1: 3D…

PDB
5E91
Type
protein
Length
297 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
TGF-beta receptor type-2
EC
2.7.11.30
UniProt
P37173
Ligands
5L4
Pockets
4 · best druggability 0.67

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATGF-beta receptor type-2 (EC 2.7.11.30)protein29739% helix, 19% strandP37173

Ligands and binding sites

  • 5L4 · 3-amino-6-[4-(2-hydroxyethyl)phenyl]-N-[4-(morpholin-4-yl)pyridin-3-yl]pyrazine-2-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12510.670.83355L4
2990.640.8924empty
3820.350.7524empty
4750.340.7521empty

Compared structures

  • 5E91 · TGF-beta receptor type 2 kinase domain (E431A,R433A,E485A,K488A,R493A,R495A) in complex… · the same entry in another collection · chain A against A, TM-score 1.00
  • P37173 · AlphaFold monomer V2.0 prediction for TGF-beta receptor type-2 (P37173) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.